Assessing transferability in systematic reviews of health economic evaluations - a review of methodological guidance.
Applicability
External validity
Generalisability
Health economic evaluations
Health technology assessment
Methods
Transferability
Journal
BMC medical research methodology
ISSN: 1471-2288
Titre abrégé: BMC Med Res Methodol
Pays: England
ID NLM: 100968545
Informations de publication
Date de publication:
20 02 2022
20 02 2022
Historique:
received:
18
08
2021
accepted:
02
02
2022
entrez:
21
2
2022
pubmed:
22
2
2022
medline:
22
3
2022
Statut:
epublish
Résumé
For assessing cost-effectiveness, Health Technology Assessment (HTA) organisations may use primary economic evaluations (P-HEs) or Systematic Reviews of Health Economic evaluations (SR-HEs). A prerequisite for meaningful results of SR-HEs is that the results from existing P-HEs are transferable to the decision context (e.g, HTA jurisdiction). A particularly pertinent issue is the high variability of costs and resource needs across jurisdictions. Our objective was to review the methods documents of HTA organisations and compare their recommendations on considering transferability in SR-HE. We systematically hand searched the webpages of 158 HTA organisations for relevant methods documents from 8th January to 31st March 2019. Two independent reviewers performed searches and selected documents according to pre-defined criteria. One reviewer extracted data in standardised and piloted tables and a second reviewer checked them for accuracy. We synthesised data using tabulations and in a narrative way. We identified 155 potentially relevant documents from 63 HTA organisations. Of these, 7 were included in the synthesis. The included organisations have different aims when preparing a SR-HE (e.g. to determine the need for conducting their own P-HE). The recommendations vary regarding the underlying terminology (e.g. transferability/generalisability), the assessment approaches (e.g. structure), the assessment criteria and the integration in the review process. Only few HTA organisations address the assessment of transferability in their methodological recommendations for SR-HEs. Transferability considerations are related to different purposes. The assessment concepts and criteria are heterogeneous. Developing standards to consider transferability in SR-HEs is desirable.
Identifiants
pubmed: 35184733
doi: 10.1186/s12874-022-01536-6
pii: 10.1186/s12874-022-01536-6
pmc: PMC8858549
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
52Informations de copyright
© 2022. The Author(s).
Références
Syst Rev. 2019 Jan 14;8(1):22
pubmed: 30642403
Health Econ. 2010 Mar;19(3):350-64
pubmed: 19378354
Res Synth Methods. 2020 Nov;11(6):760-779
pubmed: 32920989
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Pharmacoeconomics. 2004;22(13):857-76
pubmed: 15329031
Health Econ. 2009 Jun;18(6):629-43
pubmed: 18677724
Pharmacoeconomics. 2020 Mar;38(3):259-267
pubmed: 31930461
Value Health. 2009 Jun;12(4):409-18
pubmed: 19900249
Health Policy. 1999 Nov;49(3):161-77
pubmed: 10827295
Expert Rev Pharmacoecon Outcomes Res. 2016 Dec;16(6):723-732
pubmed: 27762640
Eur J Health Econ. 2008 Nov;9(4):311-2
pubmed: 18543010
Value Health. 2021 Apr;24(4):463-472
pubmed: 33840423
Value Health. 2010 Dec;13(8):1028-37
pubmed: 20667054
Med Decis Making. 2014 Oct;34(7):826-40
pubmed: 24713694
J Clin Epidemiol. 2013 Nov;66(11):1251-61
pubmed: 23953081
Health Technol Assess. 2004 Dec;8(49):iii-iv, 1-192
pubmed: 15544708
Cochrane Database Syst Rev. 2019 Oct 3;10:ED000142
pubmed: 31643080
Eur J Health Econ. 2005 Dec;6(4):334-46
pubmed: 16249933
Int J Technol Assess Health Care. 2018 Jan;34(6):537-546
pubmed: 30345948
Clinicoecon Outcomes Res. 2011;3:89-104
pubmed: 21935337